Viewing Study NCT05850234


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-03-11 @ 3:41 PM
Study NCT ID: NCT05850234
Status: RECRUITING
Last Update Posted: 2025-08-06
First Post: 2023-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module